ATG-021

N/A

Report date: 2026/03/23 20:03:44

Base Information

Drug NameATG-021
Drug Alias NameATG-021
ClassificationBiologics > T cell engagers
Mechanisms of ActionG-protein coupled receptor family C group 5member D modulatorsT cell surface glycoprotein CD3 modulators
TargetsG-protein coupled receptor family C group 5member DT cell surface glycoprotein CD3
Therapy Area/IndicationsMultiple MyelomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAntengene Corp Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAntengene Corp Ltd
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A